CA-LAMBDATEST
LambdaTest, a leading cloud-based unified testing platform, is excited to announce its integration with BugHerd, the Australian-based website feedback and bug tracking tool. This collaboration is designed to enhance the efficiency of identifying and logging website bug reports during the testing phase.
BugHerd is a popular website bug-tracking tool that aids organizations by enabling them to easily create and collect bug reports, and track feedback. This streamlines communication by allowing clear pinpointing of issues, while also offering task management features to track bug progress and resolution within development teams.
This integration empowers users to effortlessly report bugs discovered during LambdaTest's comprehensive cross-browser testing sessions directly to their BugHerd project. With a single click, users can generate a new BugHerd task complete with essential details, including screenshots, browser, and operating system information, and the ability to assign the task to a specific team member. This eliminates the need for manual data entry and ensures all critical information is captured for efficient bug resolution.
Mayank Bhola, Co-Founder and Head of Product at LambdaTest, commented on the integration saying, "We're thrilled to offer this integration with BugHerd. It aligns perfectly with our mission to make the lives of testers and developers easier. By combining our efforts, we're simplifying the bug tracking process which is often a major bottleneck in web development."
Setting up the BugHerd integration is straightforward—users just need to enter their BugHerd API token in the LambdaTest settings. This simple step will connect their testing workflow directly to BugHerd, enabling them to start logging bugs immediately.
This new feature is designed to be seamless and easy to use, ensuring that even teams without technical expertise can efficiently enhance their web projects. Users can effortlessly manage their testing directly from LambdaTest and see their issues updated in BugHerd without any complications.
"This integration with LambdaTest underscores our commitment to agencies and web developers by allowing them to seamlessly link browser testing with direct feedback, thereby shortening project timelines and enhancing client satisfaction," said Stephen Neville, CEO of BugHerd.
This partnership between BugHerd and LambdaTest represents a significant step forward in making web testing more integrated and efficient, allowing development teams to deliver higher-quality websites faster and with fewer issues.
For more information about BugHerd’s integration with LambdaTest, please visit https://www.lambdatest.com/support/docs/bugherd-integration/
About LambdaTest
LambdaTest is an intelligent and omnichannel enterprise execution environment that helps businesses drastically reduce time to market through Just in Time Test Orchestration (JITTO), ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.
- Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across 3000+ different browsers, real devices, and operating system environments.
- HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.
For more information, please visit: https://lambdatest.com
About BugHerd
BugHerd is an Australian-based software company whose website feedback platform is used all around the world by creative and web development agencies, SaaS companies, education, and online learning organizations.
The company officially launched to the SaaS market in 2011 and was one of the first-ever Australian teams to grace the US-based startup program 500 Startups and the Australian-based Startmate.
BugHerd gained popularity by carving a niche in the Web Developer and Designer software tool market. It solved the difficulty they faced getting contextual website feedback from non-technical folk.
With Stephen Neville at the helm as CEO, the BugHerd team is committed to helping agencies run their website development projects to budget and on time, keeping their clients happy so that they come back for more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514577994/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quectel Launches SP895BD-AP Smart Module, Powering the Next Generation of Intelligent IoT Applications5.1.2026 15:33:00 CET | Press release
Quectel Wireless Solutions, an end-to-end global IoT solutions provider, announced the official launch of its new-generation flagship smart module, the SP895BD-AP. Powered by the Qualcomm Dragonwing™ Q-8750 processor, the SP895BD-AP module boasts enhanced graphics processing capabilities, superior visual imaging effects, and advanced edge computing performance, meeting the requirements of high-end devices such as video conferencing systems, ultra-high-definition (UHD) displays, image synthesis equipment, computing power boards, smart retail terminals and smart home appliances. The SP895BD-AP redefines performance boundaries with its advanced hardware architecture. Powered by the Dragonwing Q-8750 processor built on a 3nm process, it features an 8-core high-performance Oryon™ CPU with a maximum frequency of 2×4.32 GHz + 6×3.53 GHz. Compared with the previous-generation (Series 8) chips, it achieves a 45% improvement in CPU performance and a 44% optimization in energy efficiency. This en
The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services5.1.2026 15:00:00 CET | Press release
The acquisition strengthens DIETL’s fine art logistics operations through expanded access to specialized storage, handling and customs services. The Rock-It Company announced today that DIETL has acquired multiple fine art logistics specialists, strengthening its infrastructure and expanding access to specialized services across key U.S. art markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105175923/en/ The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services The acquired companies include Delaware Freeport, Delaware National Art Company, Techno Export, and Registrar Technologies. Together, these businesses add depth across fine art storage, handling, packing, crating, installation support, customs brokerage, and technology-enabled logistics services, complementing DIETL’s existing operations. Delaware Freeport, a provider of high-security
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models5.1.2026 14:54:00 CET | Press release
Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks The Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has announced the release of Falcon H1R 7B, a next-generation AI model that takes a significant step toward making advanced AI more accessible than ever, by delivering world-class reasoning performance in a compact, efficient, and openly available format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105981339/en/ TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models (Graphic: AETOSWire) With just 7 billion parameters, Falcon H1R 7B challenges and, in many cases, outperforms larger open-source AI models from around the world, including models fr
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform5.1.2026 14:00:00 CET | Press release
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving Immune Rejection and Inheritance of Cellular Aging—The Major Hurdles of Existing Stem Cell TherapiesDrastically Improving Treatment Accessibility through the New Paradigm, ‘Patient-Initiated Clinical Trial™’, which Overcomes Existing Clinical Limitations Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic Stem Cell (Somatic Cell Nuclear Transfer-derived Embryonic Stem Cell, hereinafter SCNT-ESC)' therapy platform based on Somatic Cell Nuclear Transfer (SCNT) technology. Concurrently, the company has initiated its innovative 'Patient-Initiated Clinical Trial™' to apply this breakthrough technology directly to patients. This platform launch is evalu
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq5.1.2026 13:30:00 CET | Press release
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences trading on Nasdaq Global Market (“Nasdaq”) and on Cboe Canada under ticker symbol: HELP Helus Pharma continues to progress its portfolio of novel serotonergic agonists (“NSAs”), with the goal of developing treatments designed to redefine mental health care, including HLP004 for the treatment of generalized anxiety disorder, with Phase 2 topline data readout expected in Q1 2026 Preparations in progress for the commercialization of HLP003, Helus Pharma’s NSA in Phase 3 clinical development, which has been granted Breakthrough Therapy Designation by the FDA for the adjunctive treatment of major depressive disorder This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated Sep
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom